HMG for Combined LH/FSH and Testosterone

Introduction

Testosterone production is only half the testicular equation. While Leydig cells make testosterone in response to LH, Sertoli cells require FSH for their critical support functions. Together, these cell types create a complete, functioning testis. Most interventions target one or the other -- but what if you could support both?

Human Menopausal Gonadotropin (hMG) is exactly this: a combination of FSH and LH in approximately equal amounts. FDA-approved for fertility treatment since the 1960s, hMG provides comprehensive gonadal stimulation that supports testosterone production alongside broader testicular health.

For men seeking to optimize testosterone while preserving or restoring fertility, hMG offers a unique combination approach. In this article, you will learn how hMG supports testosterone through dual gonadotropin action, why this matters for comprehensive hormonal optimization, and how FixMyT helps you understand your testicular function within the metabolic context.

Understanding Testosterone: The Expression of Your Metabolism

Testosterone represents the apex of the FixMyT metabolic tree at Level 4: Androgen Expression. The subtitle "Expression" reflects that testosterone is the final output of everything working properly upstream.

The FixMyT framework maps testosterone as depending on:

• Foundation (Level 1): Nutrition and mitochondrial energy
• Organs (Level 2): Gut, liver, and thyroid processing
• Low Interference (Level 3): Cortisol, estrogen, prolactin, serotonin in check
• Support (Level 4): Progesterone and DHT creating optimal environment

When testosterone is low, symptoms pervade: fatigue, low libido, muscle loss, fat gain, brain fog, and depression. But testosterone production is not just about the hormone -- it requires healthy testicular function overall.

This is where hMG's dual FSH/LH action becomes relevant: it supports the complete testicular environment, not just the testosterone-producing cells.

What Is hMG?

Human Menopausal Gonadotropin is a hormonal preparation extracted from post-menopausal women's urine, containing both FSH and LH in approximately 75 IU of each per vial.

Key characteristics of hMG:

• Composition: FSH + LH (approximately 1:1 ratio)
• Classification: Gonadotropin preparation
• FDA status: Approved (Menopur, Repronex) for fertility
• Administration: Subcutaneous or intramuscular (75-150 IU, typically 2-3x weekly for males)
• Half-life: FSH ~24-48 hours, LH ~20-24 hours
• Unique feature: Dual gonadotropin activity

hMG has been a cornerstone of fertility medicine for over 60 years, providing one of the longest clinical track records of any hormonal intervention.

For the complete technical profile, see the full hMG profile on PepGuide.

How hMG Supports Testosterone Function

hMG supports testosterone through comprehensive gonadal stimulation:

1. LH Component for Testosterone

The LH activity in hMG:

• Stimulates Leydig cells directly
• Activates testosterone synthesis pathway
• Mimics the natural LH signal from the pituitary
• Supports intratesticular testosterone levels

This is similar to hCG's effect, though hMG provides a more physiological LH:FSH ratio.

2. FSH Component for Testicular Health

The FSH activity provides critical additional support:

• Stimulates Sertoli cells
• Supports the blood-testis barrier
• Enhances testicular microenvironment
• Critical for spermatogenesis
• May improve overall testicular function beyond testosterone

Sertoli cells produce factors that support Leydig cell function, so FSH indirectly supports testosterone production.

3. Synergistic Testicular Support

The combination creates comprehensive effects:

• LH and FSH work synergistically in the testis
• The testicular microenvironment is optimized
• Spermatogenesis and testosterone production are both supported
• More closely mimics natural pituitary output

4. Fertility Preservation

For men wanting to maintain or restore fertility:

• hMG supports complete spermatogenesis
• 50-80% success rates for sperm count restoration
• Often combined with hCG for optimal results
• Can restart fertility after TRT-induced suppression

5. LH-Deficient Considerations

Some men benefit specifically from the LH component:

• Primary hypogonadism with adequate FSH may need LH more
• Post-TRT recovery may require both signals
• Individual variation in which gonadotropin is more limiting

What Real People Are Saying

hMG is used in fertility and hormone optimization contexts:

"Added hMG 75 IU three times weekly to my protocol after my fertility doc explained the FSH benefit. My sperm count improved significantly over 6 months, and testosterone stayed stable. The combination seems to support the whole testicular system better than hCG alone." -- u/fertility_optimization on r/Testosterone

"Used hMG as part of my restart protocol after years on TRT. The combination of LH and FSH seemed to bring the testes back online more completely. Sperm count recovered, testosterone normalized, and I feel like everything is working as it should again." -- u/trt_to_natural on r/steroids

"My endocrinologist prescribed hMG instead of just hCG because my FSH was quite low. Within a few months, testicular volume improved, testosterone came up, and my overall sense of well-being improved. The comprehensive approach makes sense to me." -- u/complete_gonadotropin on r/Peptides

These experiences reflect hMG use in medically supervised contexts.

Monitoring Your Testosterone Health with FixMyT

Understanding how testicular function fits into your overall metabolic picture is essential. FixMyT provides this comprehensive mapping.

The FixMyT symptoms quiz evaluates:

• Testosterone symptoms (energy, libido, muscle, mood)
• Testicular function indicators (size, fertility)
• Upstream factors (nutrition, thyroid, cortisol)
• Interference patterns (estrogen, prolactin)

The visual metabolic tree shows testosterone at Level 4 depending on everything upstream. If testicular function is the limiting factor (rather than upstream interference), gonadotropin support via hMG may be highly relevant.

For those researching fertility-preserving testosterone optimization, FixMyT helps identify priorities.

Research and Considerations

hMG has extensive clinical evidence spanning over 60 years of use.

What the evidence supports:

• Dual LH/FSH activity supports complete testicular function
• 50-80% success rates for fertility restoration in hypogonadal men
• Testosterone production supported through LH activity
• Synergistic effects of combined gonadotropins
• Long safety record with well-characterized side effects

What needs monitoring:

• Estrogen levels (gonadotropins increase testosterone which can aromatize)
• Response to treatment (semen analysis, testosterone levels)
• Balance of effects (some may need more or less FSH activity)
• Cost considerations (hMG is more expensive than hCG alone)

The evidence strongly supports hMG for comprehensive gonadal support.

Disclaimer

This article is for educational purposes only. hMG is an FDA-approved prescription medication requiring medical supervision and monitoring. Nothing in this article constitutes medical advice or a recommendation to use any substance.

hMG use in males is often off-label and requires proper medical oversight. Women using hMG for fertility require intensive monitoring for ovarian hyperstimulation.

Any decisions about health interventions remain your responsibility in consultation with appropriate medical professionals.

Learn More

• Full hMG Profile on PepGuide - Complete technical details
• HCG for LH-Only Support - Alternative approach
• FixMyT Metabolic Assessment - Understand your testicular function
• Gonadorelin for Axis Support - Upstream stimulation

References

1. Huirne JA, et al. "Contemporary pharmacological manipulation in assisted reproduction." Drugs. 2004;64(3):297-322.

2. Bouloux P, et al. "Induction of spermatogenesis by recombinant FSH in hypogonadotropic males." New England Journal of Medicine. 2003;348(14):1312-1319.

3. Matorras R, et al. "Recombinant FSH versus highly purified FSH in intrauterine insemination." Fertility and Sterility. 2000;73(6):1151-1155.

4. Liu PY, et al. "Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis." Journal of Clinical Endocrinology & Metabolism. 2006;91(5):1805-1813.

5. Ramasamy R, et al. "Recovery of spermatogenesis after testosterone replacement therapy or anabolic-androgenic steroid use." Asian Journal of Andrology. 2018;20(4):365-371.